BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7311702)

  • 21. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ECG and ion changes at rest and at work in patients with chronic renal failure prior to dialysis and after (author's translation)].
    Lisý Z
    Cas Lek Cesk; 1977 Jun; 116(22):689-94. PubMed ID: 880610
    [No Abstract]   [Full Text] [Related]  

  • 23. [How long and how often to dialyse patients with chronic renal failure (author's transl)].
    Válek A; Bozek P; Melicharová D; Dzúrik R
    Cas Lek Cesk; 1977 Nov; 116(47):1461-6. PubMed ID: 597832
    [No Abstract]   [Full Text] [Related]  

  • 24. Disputed issues in renal failure therapy. Proceedings of the dialysis workshop, Bernried, March 29-31,1984.
    Contrib Nephrol; 1985; 44():1-294. PubMed ID: 3987282
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 26. [Progress in hemofiltration research (author's transl)].
    Zhang X
    Zhonghua Nei Ke Za Zhi; 1981 Jul; 20(7):439-42. PubMed ID: 7327066
    [No Abstract]   [Full Text] [Related]  

  • 27. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of small molecule removal in the control of treatment morbidity with haemodialysis and haemofiltration.
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1981; 18():249-55. PubMed ID: 7329970
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of patients with chronic renal failure in the Instituto Nacional de Pediatria, D.I.F. (author's transl)].
    Zaltzman S; Ruiz Speare O; Guzmán Flores A; Jiménez Angulo RM; García de la Puente S
    Rev Invest Clin; 1980; 32(4):443-9. PubMed ID: 7012973
    [No Abstract]   [Full Text] [Related]  

  • 30. [Glycosylated hemoglobin in renal failure (author's transl)].
    Oimomi M; Kubota S; Takagi K; Kawasaki T; Tanke G; Yoshimura Y; Takase S; Satou E; Baba S
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):259-63. PubMed ID: 7382167
    [No Abstract]   [Full Text] [Related]  

  • 31. [The study of impaired reducing power in chronic renal failure patients with emphasis on red blood cells and lipoperoxide (author's transl)].
    Kawaguchi S; Maeda K; Tsutsui S; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):401-12. PubMed ID: 7401393
    [No Abstract]   [Full Text] [Related]  

  • 32. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

  • 33. [Technic and indication for controlled ultrafiltration].
    Schmidt R; Herrera R; Holtz M; Falkenhagen D; Osten B; Klinkmann H
    Z Gesamte Inn Med; 1980 Aug; 35(16):suppl 55-8. PubMed ID: 7467575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inappropriate lactation syndrome and serum prolactin in chronic renal failure (author's transl)].
    Yoshiyama N
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):13-28. PubMed ID: 565845
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic renal failure and arterial hypertension with "favourable" and "unfavourable" response to haemodialysis--haemodynamic changes in patients (author's transl)].
    Tomásek R; Horký K; Ort J; Lachmanová J; Straková M; Benes R
    Cas Lek Cesk; 1980 Aug; 119(33-34):897-902. PubMed ID: 7438159
    [No Abstract]   [Full Text] [Related]  

  • 37. [Erythrocyte levels of ALA-dehydrase and uro-synthetase in chronic renal insufficiency (author's transl)].
    Tabernero Romo JM; Pérez Sandoval D; Rodríguez Commes JL; Rico Sánchez J; Macías Núñez JF; Corbacho Becerra L; Juanes A; de Castro S
    Med Clin (Barc); 1981 Jun; 77(2):69-71. PubMed ID: 7321629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the measurement of blood ionized calcium in patients undergoing chronic hemodialysis (author's transl)].
    Imada A; Horiuchi A; Kogi Y; Kawauchi Y
    Rinsho Byori; 1981 Nov; 29(11):1136-40. PubMed ID: 7334668
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of sodium in the prevention of vascular instability during haemodialysis.
    Man NK; Di Giulio S; Zingraff J; Sausse A; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1981; 18():255-65. PubMed ID: 7329971
    [No Abstract]   [Full Text] [Related]  

  • 40. [Haemofiltration (author's transl)].
    Descoeudres C
    Ther Umsch; 1982 May; 39(5):391-5. PubMed ID: 7101219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.